Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 6,462,017

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,462,017

Title:	Method of reducing side effects of chemotherapy in cancer patients
Abstract:	A method for reducing the severity of chemotherapy side effects in cancer patients by administering thymosin .alpha..sub.1 in conjunction with the administration of a chemotherapy agent to the patient. As a result of the reduction of post-chemotherapy side effects, patients experience an increase in the quality of life.
Inventor(s):	Rudolph; Alfred R. (Los Altos Hills, CA), Tam; Vincent Chung-Ying (Hong Kong, HK), Quan; Maggie Jie (Shanghai, CN)
Assignee:	SciClone Pharmaceuticals, Inc. (San Mateo, CA)
Application Number:	09/561,917
Patent Claims:	see list of patent claims

Details for Patent 6,462,017

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	HERCEPTIN	trastuzumab	VIAL; INTRAVENOUS	103792	001	1998-09-25	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	2036-04-30	RX	Orphan	search
Eisai Inc	ONTAK	denileukin diftitox	VIAL	103767	001	1999-02-05	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	2036-04-30	RX	Orphan	search
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	2036-04-30	RX		search
Berlex Labs	LEUKINE	sargramostim	VIAL	103362	002	1991-03-05	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	2036-04-30	RX		search
Berlex Labs	LEUKINE	sargramostim	VIAL	103362	001	1991-03-05	➤ Sign Up	SciClone Pharmaceuticals, Inc. (San Mateo, CA)	2036-04-30	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 6,462,017

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	0182949	Apr 22, 2004
World Intellectual Property Organization (WIPO)	0182949	Aug 28, 2003
World Intellectual Property Organization (WIPO)	0182949	Nov 08, 2001
Japan	2004501870	Jan 22, 2004
Hong Kong	1060280	Jun 15, 2007
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.